United Kingdom · Advertising framework
Advertising OTC medicines on websites in the United Kingdom
General market orientation, not campaign clearance. Research scope and dates
Product and service rules
Consumer medicine advertising depends on the licence and message
Regulator guidance
Eligible licensed non-prescription medicines can be advertised to the public within their authorised information. Include the applicable product, indication, ingredient and read-the-label information. Check product-specific prohibitions and the Blue Guide’s format rules; do not assume all OTC executions qualify for abbreviated information.
Sources: Advertise your medicines; MHRA Blue Guide: advertising and promoting medicines
Check current licence territory after the Windsor changes
Regulator guidance
From 1 January 2025 medicines are generally authorised UK-wide. Existing PLGB licences generally became UK-wide without changing their number, so the prefix alone is not evidence of GB-only scope. Verify the actual licence and current product information; an EU authorisation no longer supplies the former Northern Ireland basis. UK-wide authorisation does not remove the prohibition on public prescription-medicine advertising.
Sources: Windsor Framework medicines — licensing and promotion
Channel rules
Check the complete consumer-facing message
Regulator guidance
The DMCC consumer-protection regime addresses misleading claims, deceptive overall presentation and material omissions. Support factual statements with evidence and present important conditions in time for an informed decision. Review prices, qualifications and commercial intent alongside the health-sector requirements.
Sources: Unfair commercial practices: CMA207
Review the whole website journey
Editorial recommendation
Review the product card, metadata, testimonials, booking page and checkout together. Archive the published version and check third-party widgets after updates.
Campaign workflow
OTC Medicines: prepare the review
Editorial recommendation
Confirm the exact product qualifies for consumer advertising in this country. Match each indication, dosage and safety statement to the current local product information. Obtain the applicable warning wording and format rules before buying space.
Keep a traceable campaign decision
Editorial recommendation
Keep one review record linking the offer, local market status, claim evidence, exact creative, media settings and any regulatory or professional clearance. Record who checked each condition. Reopen the review when the offer, claim, source rule or execution changes.
Pre-publication checklist
- Confirm the exact product qualifies for consumer advertising in this country.
- Match each indication, dosage and safety statement to the current local product information.
- Obtain the applicable warning wording and format rules before buying space.
- Record product or provider eligibility before approving claims.
- Archive the final creative and its evidence, permissions and review decisions.
- Assign an owner for source updates, complaints and prompt withdrawal of inaccurate material.
Scope and unresolved questions
- Windsor medicine licensing and the GB/NI device distinction are now documented. Verify the exact authorisation, certificate validity, transitional eligibility and destination market. Food-claim transitions, other professional regulators and broadcaster-specific clearance remain separate checks.
- This national baseline does not review every broadcaster rule, platform policy, regional licensing condition, promotion mechanic or data-transfer arrangement. No format-specific warning dimensions or durations should be inferred where none are supplied.
Research scope, introduction and dates
For OTC medicines on websites in the United Kingdom, confirm the advertising status of the exact product. This framework connects the locally permitted uses with the information, warnings and execution checks relevant to the selected channel.
On a website, the headline, product card, testimonial, embedded video and booking or checkout page all contribute to the message. Follow the rules below across that journey, rather than reviewing the landing-page text in isolation.
General market orientation, not legal, regulatory or medical advice, a complete compliance plan or clearance of an advertisement. Actual requirements depend on the specific offer and campaign.
How to use this national baseline
Editorial overview
This framework combines researched national rules with editorial review steps. UK advertising baseline with a required Great Britain versus Northern Ireland product-regime check. A visible channel workflow does not establish that the selected product or service may be advertised there. Read the category restrictions first.
The review date identifies when the cited provisions or regulator excerpts were checked. It does not mean that every local rule, exception, professional standard or platform policy has been reviewed.
Sources
- Advertise your medicines
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- MHRA Blue Guide: advertising and promoting medicines
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- Unfair commercial practices: CMA207
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- Windsor Framework medicines — licensing and promotion
Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.
From framework to action
Local expertise in United Kingdom
Find support with medical and health marketing, marketing and sales advice, or organizing your business and coordinating projects in United Kingdom.
Medical & health marketing
No partners listed in this category yet.
Marketing & sales advisory
No partners listed in this category yet.
Business & project coordination
No partners listed in this category yet.
Join the local partner directory
Would you like your company to be listed?
Talk to us about the terms of a listing. Leave your details and we will get in touch.